Soleo Connect®
Patient Education
Bill Pay
Search for:
About
Company
About Our Company
Leadership
Careers
News
Blogs
Our Locations
Serving You Wherever You Are
See All
Who We Serve
We Serve
Patients
Getting Started
Patient Education
Patient Stories
Providers
Pharma
Clinical Abstracts and Case Studies
Payors
Health Systems
Therapeutics
Conditions Treated
Rare and Orphan Diseases
Allergy and Asthma
Anti-Infective Therapy
Bleeding Disorders
Factor X Deficiency
Cardiovascular
Chronic Inflammatory Disorders
Rheumatoid Arthritis
Gastrointestinal
Crohn’s Disease and Ulcerative Colitis
Nutrition Support
Immunoglobulin Therapy
Primary Immunodeficiency
Neurological Disorders
Alzheimer’s Disease
GBS and CIDP
Multiple Sclerosis
Myasthenia Gravis
Ophthalmologic Conditions
Thyroid Eye Disease
Referrals
See All
Drug List
See all
SoleoRare™
Locations
Referrals
Careers
Contact Us
Home
Who We Serve
Patients
Daisy Award
Drug List
Patient Education
Patient Stories
Providers
Pharma
Clinical Abstracts and Case Studies
SoleMetrics®
Payors
Health Systems
Therapeutics
Rare Diseases
Myositis
Plasminogen Deficiency
Allergy and Asthma
Anti-Infective Therapy
Bleeding Disorders
Factor X Deficiency
Cardiovascular
Chronic Inflammatory Disorders
Rheumatoid Arthritis
Immunoglobulin Therapy
Primary Immunodeficiency
Gastrointestinal
Crohn’s Disease and Ulcerative Colitis
Nutrition Support
Neurological Disorders
Alzheimer’s Disease
GBS and CIDP
Myasthenia Gravis
Multiple Sclerosis
Ophthalmologic Conditions
Thyroid Eye Disease Treatment
Referrals
See All
Drug List
Locations
About
About Our Company
Leadership
News
Blogs
SoleoRare
Careers
Bill Pay
Soleo Connect®
Referrals
Contact Us
Search for:
April 20, 2026
Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, a Specialty Pharmacy Focused on Complex Patient Needs
Read More
Search
Category
All Categories
Abstracts/Posters/Research
Accreditations
Anniversary
Awards
New Leader
New Location
New Partnership
New Product
New Service
Partnership
Uncategorized
July 16, 2024
Soleo Health Selected as a Specialty Pharmacy Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
Read More
July 1, 2024
‘Fiercely Independent’ Soleo Health Maps Its Future
Read More
May 6, 2024
Soleo Health Selected as a Specialty Pharmacy Partner of Ryplazim® for Plasminogen Deficiency Type 1 (PLGD-1) Treatment
Read More
April 29, 2024
Soleo Health Unveils Pharmacy in Jackson, MS; Marks Pharmacy Entry Into State
Read More
March 7, 2024
Soleo Health Celebrates 10 Years of Simplifying Complex Care for Patients
Read More
September 27, 2023
Soleo Health Named a Fastest-Growing Middle Market Company by Dallas Business Journal for Sixth Consecutive Year
Read More
September 14, 2023
IMS Wins Renewal of Soleo Health Contract, Demonstrating Leadership in the Alternate Site Market
Read More
August 7, 2023
Soleo Health Unveils Boise, Idaho, State-of-the-Art Pharmacy and Infusion Center
Read More
August 1, 2023
Soleo Health Marks Its Entry Into the Cincinnati Market With Opening of State-of-the-Art Pharmacy and Infusion Center in Blue Ash, Ohio
Read More
July 7, 2023
Soleo Health Prepared to Meet Increased Demand of FDA-Approved LEQEMBI™ (lecanemab-irmb) to Treat Alzheimer’s Disease
Read More
No results were found for the selected filters.
Load More